Patents by Inventor Sharon DeMorrow

Sharon DeMorrow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GALANIN- AND GALANIN RECEPTOR BASED COMPOUNDS FOR THE TREATMENT OF LIVER FIBROSIS
    Publication number: 20220233640
    Abstract: In one aspect, the invention relates to pharmaceutical compositions comprising at least one agent that modulates GalR1 and/or GalR, which are useful for treating fibrotic disorders such as, for example, liver fibrosis. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: April 16, 2020
    Publication date: July 28, 2022
    Inventors: Sharon Demorrow, Matthew McMillin, Anca D. Petrescu
  • Cholesterol lowering drugs for the treatment of hepatic encephalopathy
    Patent number: 11160826
    Abstract: The present disclosure is concerned with cholesterol lowering agents including, but not limited to, statins and cyclodextrins, for the treatment of hepatic encephalopathy. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Grant
    Filed: October 24, 2019
    Date of Patent: November 2, 2021
    Assignee: United States Government as represented by the Department of Veterans Affairs
    Inventors: Sharon Demorrow, Matthew MacMillin
  • Melatonin-based treatment and diagnosis of bile duct disease
    Patent number: 9468670
    Abstract: Methods and composition for a melatonin signaling modulator-based diagnosis and therapy are described. For example, in certain aspects methods for administering an anti-tumor therapy using a melatonin signaling modulator are described. Furthermore, the invention provides compositions and methods for detecting biliary tract disease such as cholangiocarcinoma.
    Type: Grant
    Filed: April 2, 2012
    Date of Patent: October 18, 2016
    Assignees: Texas A&M University System, The United States of America as Represented by the Department of Veterans Affairs, Scott & White Healthcare
    Inventors: Gianfranco Alpini, Sharon DeMorrow, Shannon Glaser
  • MELATONIN-BASED TREATMENT AND DIAGNOSIS OF BILE DUCT DISEASE
    Publication number: 20140079680
    Abstract: Methods and composition for a melatonin signaling modulator-based diagnosis and therapy are described. For example, in certain aspects methods for administering an anti-tumor therapy using a melatonin signaling modulator are described. Furthermore, the invention provides compositions and methods for detecting biliary tract disease such as cholangiocarcinoma.
    Type: Application
    Filed: April 2, 2012
    Publication date: March 20, 2014
    Applicant: SCOTT & WHITE HEALTHCARE
    Inventors: Gianfranco Alpini, Sharon DeMorrow, Shannon Glaser